Biogen Analysts Boost Their Forecasts Following Upbeat Q1 Earnings

Benzinga

Apr 30

Biogen (NASDAQ:BIIB) reported upbeat earnings for the first quarter on Wednesday.

The company posted quarterly earnings of $3.57 per share which beat the analyst consensus estimate of $3.01 per share. The company reported quarterly sales of $2.478 billion which beat the analyst consensus estimate of $2.255 billion.

Biogen cut its FY2026 adjusted EPS guidance from $15.25-$16.25 to $14.25-$15.25.

Biogen shares fell 1.3% to trade at $191.84 on Thursday.

These analysts made changes to their price targets on Biogen following earnings announcement.

Wedbush analyst Laura Chico maintained Biogen with a Neutral and raised the price target from $191 to $196.
Guggenheim analyst Yatin Suneja maintained the stock with a Buy and raised the price target from $246 to $260.

Considering buying BIIB stock? Here’s what analysts think:

Photo via Shutterstock

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2631654890"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2631654890\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2631654890?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-30 23:57","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2631654890","market":"hk","top_or_hot":-1,"title":"Biogen Analysts Boost Their Forecasts Following Upbeat Q1 Earnings","media":"Benzinga","content":"<html><body><p><strong>Biogen</strong> (NASDAQ:BIIB) reported upbeat earnings for the first quarter on Wednesday.</p>\n<p>The company posted quarterly earnings of $3.57 per share which beat the analyst consensus estimate of $3.01 per share. The company reported quarterly sales of $2.478 billion which beat the analyst consensus estimate of $2.255 billion.</p>\n<p>Biogen cut its FY2026 adjusted EPS guidance from $15.25-$16.25 to $14.25-$15.25.</p>\n<p>Biogen shares fell 1.3% to trade at $191.84 on Thursday.</p>\n<p>These analysts made changes to their price targets on Biogen following earnings announcement.</p>\n<ul>\n<li>Wedbush analyst Laura Chico maintained Biogen with a Neutral and raised the price target from $191 to $196.</li>\n<li>Guggenheim analyst Yatin Suneja maintained the stock with a Buy and raised the price target from $246 to $260.</li>\n</ul>\n<p><strong>Considering buying BIIB stock? Here’s what analysts think:</strong> </p>\n<figure><img decoding=\"async\" height=\"472\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/04/30115549/image-726-1024x472.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/04/30115549/image-726-1024x472.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/04/30115549/image-726-300x138.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/04/30115549/image-726-768x354.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/04/30115549/image-726.png 1232w\" width=\"1024\"/></figure>\n<p><em>Photo via Shutterstock</em></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biogen Analysts Boost Their Forecasts Following Upbeat Q1 Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiogen Analysts Boost Their Forecasts Following Upbeat Q1 Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2026-04-30 23:57</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p><strong>Biogen</strong> (NASDAQ:BIIB) reported upbeat earnings for the first quarter on Wednesday.</p>\n<p>The company posted quarterly earnings of $3.57 per share which beat the analyst consensus estimate of $3.01 per share. The company reported quarterly sales of $2.478 billion which beat the analyst consensus estimate of $2.255 billion.</p>\n<p>Biogen cut its FY2026 adjusted EPS guidance from $15.25-$16.25 to $14.25-$15.25.</p>\n<p>Biogen shares fell 1.3% to trade at $191.84 on Thursday.</p>\n<p>These analysts made changes to their price targets on Biogen following earnings announcement.</p>\n<ul>\n<li>Wedbush analyst Laura Chico maintained Biogen with a Neutral and raised the price target from $191 to $196.</li>\n<li>Guggenheim analyst Yatin Suneja maintained the stock with a Buy and raised the price target from $246 to $260.</li>\n</ul>\n<p><strong>Considering buying BIIB stock? Here’s what analysts think:</strong> </p>\n<figure><img decoding=\"async\" height=\"472\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/04/30115549/image-726-1024x472.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/04/30115549/image-726-1024x472.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/04/30115549/image-726-300x138.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/04/30115549/image-726-768x354.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/04/30115549/image-726.png 1232w\" width=\"1024\"/></figure>\n<p><em>Photo via Shutterstock</em></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BIIB","symbol_name":"渤健公司","start_time":0,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/04/52180397/biogen-analysts-boost-their-forecasts-following-upbeat-q1-earnings","article_id":"2631654890","we_media_id":"1052270027","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2631654890","pubTimestamp":1777564626,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Benzinga","introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"summary":"Biogen (NASDAQ:BIIB) reported strong Q1 earnings, beating expectations. However, they cut their FY2026 EPS guidance. Analysts have mixed opinions on buying BIIB stock.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"BIIB":"渤健公司"},"translate_title":"百健(Biogen)分析师在第一季度盈利乐观后上调预测","themeId":"11c8fbbf839f433c9d274cef5f173382","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BIIB":1.5},"content_text":"Biogen (NASDAQ:BIIB) reported upbeat earnings for the first quarter on Wednesday.\nThe company posted quarterly earnings of $3.57 per share which beat the analyst consensus estimate of $3.01 per share. The company reported quarterly sales of $2.478 billion which beat the analyst consensus estimate of $2.255 billion.\nBiogen cut its FY2026 adjusted EPS guidance from $15.25-$16.25 to $14.25-$15.25.\nBiogen shares fell 1.3% to trade at $191.84 on Thursday.\nThese analysts made changes to their price targets on Biogen following earnings announcement.\n\nWedbush analyst Laura Chico maintained Biogen with a Neutral and raised the price target from $191 to $196.\nGuggenheim analyst Yatin Suneja maintained the stock with a Buy and raised the price target from $246 to $260.\n\nConsidering buying BIIB stock? Here’s what analysts think: \n\nPhoto via Shutterstock","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"express","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}